Vaccination is the most effective and best way to avoid the disease of COVID-19.
COVID-19
vaccines
Journal
Immunity, inflammation and disease
ISSN: 2050-4527
Titre abrégé: Immun Inflamm Dis
Pays: England
ID NLM: 101635460
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
revised:
26
06
2023
received:
24
08
2022
accepted:
06
07
2023
medline:
1
9
2023
pubmed:
30
8
2023
entrez:
30
8
2023
Statut:
ppublish
Résumé
Most of the vaccines that are effective against SARS-CoV-2 have used the following functional strategies: inactivated viruses, live attenuated viruses, viral vector-based vaccines, subunit vaccines, recombinant proteins, and DNA/RNA vaccines. Among the vaccines that stimulate the host's immune system with the help of DNA are: undergoing Phase 2/3 trials including INO-4800 (International Vaccine Institute; Inovio Pharmaceuticals), Symvivo, Canada-COVID19 (AnGes, Inc.); GX-19 (Genexine, Inc.). BNT162b2 and mRNA-1273 vaccines were made by BioNTech/Pfizer/Fosun Pharma group and Moderna/NIAID group, respectively, which are considered as types of RNA vaccines. Vaccines that are based on the viral vector are AstraZeneca, Sputonium, and Johnson-Jensen. Among the inactive viral vaccines, the following can be mentioned: CoronaVac (Sinovac) WIBP vaccine (Wuhan Institute of Biological Products, Sinopharm), BBIBPCorV (Beijing Institute of Biological Products, Sinopharm), BBV152/Covaxin (Bharat Biotech, ICMR, National Institute of Virology) And among the protein-based/subunit vaccines, the following can be counted: NVX-CoV2373: (Novavax); SCB-2019 vaccine (Clover Biopharmaceuticals AUS Pty Ltd.); Covax-19 (GeneCure Biotechnologies; Vaxine Pty Ltd.) mRNA vaccines, viral vector vaccines, and protein subunit vaccines cannot cause disease because these vaccines stimulate the immune system to produce antibodies against virus proteins instead of the virus itself (or its antigen). MRNA vaccines increase SARS-CoV-2 proteins and ultimately stimulate the production of T and B lymphocytes. The epidemic of HCoVs and their destructive and harmful effects on life has caused the scientific community to seek the production of an effective and efficient vaccine before its catastrophic release. We all need to know that none of us will be healed until the other is healed. The purpose of this review article is to present a selection of existing knowledge in the field of fighting and preventing the coronavirus.
Identifiants
pubmed: 37647441
doi: 10.1002/iid3.946
pmc: PMC10408370
doi:
Substances chimiques
sinovac COVID-19 vaccine
0
SCB-2019 COVID-19 vaccine
0
BIBP COVID-19 vaccine
0
BBV152 COVID-19 vaccine
76JZE5DSN6
BNT162 Vaccine
0
Biological Products
0
Viral Vaccines
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e946Informations de copyright
© 2023 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.
Références
Hum Vaccin Immunother. 2022 Dec 31;18(1):2002083
pubmed: 35130825
Lancet Gastroenterol Hepatol. 2020 Apr;5(4):335-337
pubmed: 32087098
N Engl J Med. 2020 Nov 12;383(20):1920-1931
pubmed: 32663912
BMJ. 2020 Oct 13;371:m3967
pubmed: 33051241
Evid Based Ment Health. 2021 May;24(2):47-48
pubmed: 33849994
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
MMWR Morb Mortal Wkly Rep. 2021 Jan 29;70(4):125-129
pubmed: 33507892
Nat Med. 2021 Apr;27(4):620-621
pubmed: 33558724
Nature. 2020 Oct;586(7830):589-593
pubmed: 32785213
Lancet Infect Dis. 2022 Jan;22(1):64-72
pubmed: 34411532
Crit Care Med. 2021 Apr 1;49(4):598-622
pubmed: 33591008
N Engl J Med. 2021 Oct 7;385(15):1393-1400
pubmed: 34525275
MMWR Morb Mortal Wkly Rep. 2021 May 21;70(20):749-752
pubmed: 34014913
Am J Obstet Gynecol. 2021 Jan;224(1):35-53.e3
pubmed: 32739398
N Engl J Med. 2021 Aug 12;385(7):585-594
pubmed: 34289274
MMWR Morb Mortal Wkly Rep. 2021 Jan 22;70(3):95-99
pubmed: 33476315
Lancet. 2021 Oct 16;398(10309):1407-1416
pubmed: 34619098
JAMA Netw Open. 2021 Apr 1;4(4):e216556
pubmed: 33830226
N Engl J Med. 2021 Aug 12;385(7):664-666
pubmed: 34233096
Am J Obstet Gynecol MFM. 2021 Mar;3(2):100295
pubmed: 33516986
Curr Med Chem. 2022;29(1):4-18
pubmed: 34355678
Arch Med Res. 2021 Jan;52(1):15-24
pubmed: 32950264
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
MMWR Morb Mortal Wkly Rep. 2021 Aug 13;70(32):1094-1099
pubmed: 34383735
Curr Opin Immunol. 2021 Aug;71:111-116
pubmed: 34330017
MMWR Morb Mortal Wkly Rep. 2021 Mar 05;70(9):329-332
pubmed: 33661860
BMJ. 2021 Aug 24;374:n2096
pubmed: 34429279
MMWR Morb Mortal Wkly Rep. 2021 Sep 24;70(38):1337-1343
pubmed: 34555004
Obstet Gynecol. 2021 Mar 1;137(3):408-414
pubmed: 33370015
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
PLoS Pathog. 2018 Aug 13;14(8):e1007236
pubmed: 30102747
Environ Chem Lett. 2021;19(2):1773-1777
pubmed: 33551702
Trends Microbiol. 2013 Oct;21(10):544-55
pubmed: 23770275
Biol Sex Differ. 2020 May 25;11(1):29
pubmed: 32450906
EClinicalMedicine. 2020 Jul 03;24:100426
pubmed: 32766541
Int J Oral Sci. 2020 Feb 24;12(1):8
pubmed: 32094336
Cell Mol Life Sci. 2021 Jan;78(2):531-544
pubmed: 32780149
Nature. 2021 May;593(7858):266-269
pubmed: 33767447
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
N Engl J Med. 2021 May 13;384(19):1824-1835
pubmed: 33440088
Front Immunol. 2020 Jul 10;11:1648
pubmed: 32754159
MMWR Morb Mortal Wkly Rep. 2020 Jun 19;69(24):759-765
pubmed: 32555134
Oral Dis. 2022 Nov;28 Suppl 2:2326-2336
pubmed: 33991381
Nat Med. 2021 Dec;27(12):2136-2143
pubmed: 34728831
Front Public Health. 2020 Apr 29;8:152
pubmed: 32411652